Stay updated on Tislelizumab & Sitravatinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe record history now includes a new revision entry: Revision: v3.6.6, replacing the previous Revision: v3.6.5.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page history shows a new site revision (v3.6.5) replacing v3.6.4, indicating a deployment update rather than changes to study data.SummaryDifference0.1%

- Check42 days agoChange DetectedThe history page shows the revision tag updated from v3.6.3 to v3.6.4, indicating a software update to the page's interface. The change does not modify study data, outcomes, or other substantive content.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a new revision tag 'Revision: v3.6.3' to the study record history. The previous revision tag 'Revision: v3.6.2' is removed from the current history view.SummaryDifference0.1%

- Check70 days agoChange DetectedThe history now includes a new page revision labeled v3.6.2, replacing the previous v3.6.0 entry.SummaryDifference0.1%

- Check85 days agoChange DetectedRecruitment status updated to indicate no more participants are being sought. A new Revision: v3.6.0 was added and the previous Revision: v3.5.5 entry was removed.SummaryDifference0.5%

Stay in the know with updates to Tislelizumab & Sitravatinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.